4-Bromo-N-methylcathinone

From Wikipedia, the free encyclopedia
4-Bromomethcathinone
Systematic (IUPAC) name
(RS)-1-(4-bromophenyl)-2-methylaminopropan-1-one
Clinical data
Legal status ?
Identifiers
CAS number 486459-03-4 YesY
ATC code ?
PubChem 1807 CID 10421832 1807
ChemSpider 8597261 YesY
Chemical data
Formula C10H12BrNO 
Mol. mass 242.11 g/mol
 YesY (what is this?)  (verify)

4-Bromomethcathinone (4-BMC, Brephedrone) is a psychoactive drug and research chemical of the phenethylamine, amphetamine, and cathinone chemical classes. It acts as a serotonin and norepinephrine reuptake inhibitor,[1][2] but acts more like an antidepressant than a stimulant.[3] It is currently unclear whether the 4-halogenated cathinones share the selective serotonergic neurotoxicity of their corresponding amphetamines.

See also

References

  1. Foley, Kevin F., Cozzi, Nicholas V. (1999) "Bromine substitution at the ring 3- or 4-position of methcathinone enhances potency at serotonin uptake transporters". Society for Neuroscience Abstracts, 25, 678.17
  2. Foley, Kevin F., Cozzi, Nicholas V. (2002). "Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs". Naunyn-Schmiedeberg's archives of pharmacology 365 (6): 457–61. doi:10.1007/s00210-002-0532-3. PMID 12070759. 
  3. Foley, Kevin F., Cozzi, Nicholas V. (2003). "Novel aminopropiophenones as potential antidepressants". Drug Development Research 60 (4): 252. doi:10.1002/ddr.10297. 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.